Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
Mariam KayleJhaqueline ValleSusan PaulukonisJane L HollPaula TanabeDustin D FrenchRavi GargRobert I LiemSherif M BadawyMarsha J TreadwellPublished in: Pediatric blood & cancer (2020)
Medicaid expansion does not appear to have improved enrollment or acute healthcare utilization among individuals with SCD in California. Future studies should explore whether individuals with SCD transitioned to other insurance plans or became uninsured postexpansion, the underlying reasons for low hydroxyurea utilization, and the lack of effect on hospital admissions despite a modest effect on ED visits.